Psoriasis is more than skin deep. It's a chronic condition where the immune system attacks the body, causing painful, scaly patches. For millions, current treatments don't work well enough. But a new study offers hope by pointing to specific proteins in the blood that might be driving the disease.
Researchers analyzed genetic data from over 36,000 people with psoriasis. They looked for proteins in the blood that are genetically linked to the condition. They found 78 such proteins. Of these, 27 showed strong evidence of a direct connection, meaning they might actually cause psoriasis rather than just be markers.
Using advanced techniques, they narrowed down to 12 top proteins, including STX4, FLT3, and IL18. These proteins are involved in immune signaling and inflammation. Importantly, many of them are already targets for existing drugs, which could speed up the process of developing new psoriasis treatments.
This is an early-stage study, not a clinical trial. The findings are based on genetic predictions, not direct experiments. But they provide a valuable roadmap for future research. If these proteins are confirmed, they could lead to new therapies that work better for people who don't respond to current options.
Common questions
What did the study find?
The study found 78 proteins in the blood that are genetically linked to psoriasis. Of those, 27 had strong evidence of a direct connection, and 12 were identified as top potential drug targets. These proteins might play a role in causing psoriasis, so they could be targets for new treatments.
Who was in the study?
The study included genetic data from 36,466 people with psoriasis. It was a meta-analysis, meaning it combined data from multiple studies. The researchers used genetic techniques to look for links between blood protein levels and psoriasis risk.
What are the potential drug targets?
The 12 top proteins are STX4, FLT3, NFKB1, IL18, PRSS53, SPAG1, SGSH, PLAT, RALB, TNFSF11, SPHK2, and STAT3. These proteins are involved in immune function and inflammation. Some are already targets for drugs used for other conditions, which might help speed up development of new psoriasis treatments.
Is this a cure for psoriasis?
No, this is not a cure. It's a genetic study that identifies potential drug targets. The findings are early and need more research. But they could lead to new treatments that work better for people who don't respond to current options. Always talk to your doctor about treatment choices.
